6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
Dexamethasone in Hospitalized Patients with Covid-19.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2020 – Sep 2025Where it's discussed
-
News617 articles
-
X / Twitter377 posts
-
Blogs66 articles
-
Facebook47 posts
-
YouTube8 videos
-
Reddit8 posts
-
Bluesky6 posts
AI synopsis
What people are saying
The discussions frequently reference the RECOVERY trial, for instance, noting that dexamethasone reduced mortality rates among patients requiring oxygen or mechanical ventilation. Words and phrases such as 'game changer,' 'cornerstone of treatment,' and 'saves lives' are prevalent, indicating both the transformative nature of the research and the enthusiasm surrounding its application. Participants also engage in a wider debate on the complexities and historical context of treatment approaches, reflecting a serious consideration of the topic.
The majority of discussions strongly support the findings of the publication, highlighting the effectiveness of dexamethasone in reducing mortality among hospitalized COVID-19 patients.
There is a high level of curiosity about the implications of the research, with many participants discussing its significance.
Contributors display deep engagement by referencing the RECOVERY trial and debating nuances of the treatment's application and effects.
The consensus is that the research has had a profound impact on COVID-19 treatment protocols, with many acknowledging its role in saving lives.
Abstract in brief
- Dexamethasone was tested in a controlled trial involving hospitalized Covid-19 patients to assess its effect on 28-day mortality compared to usual care.
- Among the 2104 patients receiving dexamethasone, 22.9% died within 28 days, compared to 25.7% in the usual care group, indicating a significant reduction in mortality.
- The drug showed particularly beneficial effects for patients needing invasive mechanical ventilation and those requiring supplemental oxygen, but had no notable impact on patients not needing any respiratory support.
Top posts
Most liked on X and Bluesky新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/fij0L0EbW6
Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in Hospitalized Patients with COVID-19'! Find out more
Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red line, the better. Note when not on oxygen, dexa has 'slight' opposite effect (not significant) Steroid misuse can help the virus! https://t.co/5g3daoRFvE https://t.co/ab2E5JuguX
We were told that the system was rigged and that no cheap generic drug would therefore ever be studied and much less FDA authorized for COVID-19. Then dexamethasone came along and blew up that narrative. It's now the cornerstone of inpatient management. https://t.co/uB5ZZTkU7D
Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors that might help explain why we’re seeing this trend. https://t.co/2zpxTIiCOy https://t.co/o25gP55j28
All mentions
Critical Analysis of RFK Jr.'s Impact on Public Health Policy
Science denial is dangerous no matter who promotes it, especially when it comes from political leaders. This video offers a detailed analysis of RFK Jr.'s views and policies during his tenure as Secretary of Health…
Factors Contributing to Decreased COVID-19 Fatality Rates
Near the end of 2020, COVID-19 fatality rates began to drop. This video explores several factors that contribute to this trend, including the impact of treatments like dexamethasone, which showed significant mortality…
Comparison of SARS-CoV-2 Omicron and Delta Variants in Cell Entry Mechanisms
The Omicron variant of SARS-CoV-2 exhibits less efficient replication and cell fusion activity compared to the Delta variant, particularly in TMPRSS2-expressing cells. It primarily uses the endocytic pathway for…
Understanding Interleukin-6 as a Predictor for Severe COVID-19 Outcomes
This study investigates interleukin-6 (IL-6) as a predictive marker for severe COVID-19, especially hypoxemia, in elderly long-term care residents. Elevated IL-6 levels can help identify high-risk patients early for…
Interleukin-6 as a Predictor of Severe COVID-19 in Elderly Patients
The study investigates interleukin-6 (IL-6) as a predictive marker for severe COVID-19, especially hypoxemia, in elderly residents of a long-term care facility. Higher initial IL-6 levels are strongly associated with…
Interleukin-6 as a Predictor of Severe COVID-19 in Elderly Patients
This study explores interleukin-6 (IL-6) as a predictive marker for severe COVID-19, especially hypoxemia, in elderly residents of long-term care facilities. Higher initial IL-6 levels are strongly associated with more…
Interleukin-6 as a Predictor of Severe COVID-19 in Elderly Patients
This study investigates interleukin-6 (IL-6) as a predictive marker for severe COVID-19, particularly hypoxemia, in elderly residents of a long-term care facility. Higher initial IL-6 levels were strongly associated…
IL-6 as a Predictive Marker for Severe COVID-19 Outcomes
This video discusses the role of interleukin-6 as a predictive marker for severe COVID-19, especially hypoxemia, in elderly residents of long-term care facilities. Early detection using IL-6 levels can assist in timely…
Interleukin-6 as a Predictor of Severe COVID-19 in Elderly Patients
This study examines interleukin-6 levels as a predictive marker for severe COVID-19, especially hypoxemia, in elderly residents of a long-term care facility. Higher initial IL-6 levels were strongly associated with…
Interleukin-6 as a Predictor of Severe COVID-19 Outcomes in Elderly Patients
The study investigates interleukin-6 as a predictive marker for severe COVID-19, particularly hypoxemia, in elderly residents of a long-term care facility. Higher initial IL-6 levels were strongly associated with…
Interleukin-6 as a Predictor for Severe COVID-19 in Elderly Patients
This study investigates interleukin-6 (IL-6) as a predictive marker for severe COVID-19, particularly hypoxemia, in elderly residents of a long-term care facility. It highlights IL-6's potential use in early screening…
IL-6 as a Predictor of Severe COVID-19 Outcomes in Elderly Patients
This video discusses the role of interleukin-6 as a predictive marker for severe COVID-19, especially hypoxemia, in elderly long-term care residents. Early identification using IL-6 levels can enable timely intervention…
Efficacy of Treatments for COVID-19 Management and Dexamethasone Insights
This video discusses the effectiveness of various COVID-19 treatments. Dexamethasone was highlighted for its significant reduction in mortality among hospitalized patients, especially those on mechanical ventilation or…
Interleukin-6 as a Predictor of Severe COVID-19 Outcomes in Elderly Patients
Dr Kiran clarifies doubts about COVID new variants and discusses the role of interleukin-6 as a predictive marker for severe COVID-19, especially hypoxemia, in elderly long-term care residents based on recent research.
Relaxation Exercises for Stress Relief | Calm in the Midst of Chaos | CALMiSM by Dr Kiran Part 3
డాక్టర్లు దేవుళ్ళు..పరుచూరి మల్లిక్ | Chemical Engineer Mallik Salute to Doctors | Dr Kiran(USA)
PET System for Stress-Free Living | CALMiSM by Dr Kiran Part 4
COVID-19 seroprevalence and immunity insights from Delhi and India.
Seroprevalence of almost 30 in Delhi suggests infection fatality rate is as low as 0.06. A significant decline in new cases indicates progress towards herd immunity, with strong T cell responses playing a key role in…
Dr Kiran(USA) Reply to Paruchuri Mallik 57 Questions About COVID 19 Part-3 | Dr Calm Sanjeevani
Dr Kiran(USA) Reply to Paruchuri Mallik 57 Questions About COVID 19 Part-4 | Dr Calm Sanjeevani
Dr Kiran(USA) Reply to Paruchuri Mallik 57 Questions About COVID 19 Part-5 | Dr Calm Sanjeevani
Dr Kiran(USA) Reply to Paruchuri Mallik 57 Questions About COVID 19 Part-6 | Dr Calm Sanjeevani
Dr Kiran(USA) Reply to Paruchuri Mallik 57 Questions About COVID 19 Part-7 | Dr Calm Sanjeevani
Cytokines, COVID-19, and YOU!
Marc Auerbach: Getting Emergency Departments Kid-Ready
Evaluating Therapeutics in COVID-19: Focus on Remdesivir Effectiveness
The RECOVERY trial investigated effective COVID-19 treatments. Remdesivir significantly reduced median recovery time from 15 to 10 days and improved clinical outcomes, showing it is a safe and more effective option for…
COVID and CV Public Health Trials 2021: Promoting We vs I
Importantly, part of this is treatable with a cheap drug, Dexamethasone. https://www.nejm.org/doi/full/10.1056/NEJMoa2021436 Neutrophils and monocytes/macrophages play an important role in the initial clear-up and repair response. But, in some patients this response is not timely switched off. 5/7
RT @RogerSeheult: @JimeeLiberty @brianmocogni Jim Jim Jim you mean after everything you've learned from me you still can't remember: Stero…
@JimeeLiberty @brianmocogni Jim Jim Jim you mean after everything you've learned from me you still can't remember: Steroids good for COVID https://t.co/nEEpPGcMPR BAD for flu https://t.co/Em2ws9jfzP.
SOURCES: Dexamethasone COVID-19 Evidence: RECOVERY Trial: https://t.co/f77ty06CjZ Dexamethasone mechanisms: https://t.co/zL3Untpzwy Anti-inflammatory PK/PD modeling: https://t.co/uAsEFDe2is Ivermectin Anti-Inflammatory Mechanisms: NF-κB inhibition (Zhang et al.):
RT @ymori117: デキサメサゾンのCOVID-19に対する死亡リスク減少効果は、酸素吸入を要する中等症以上に限られるようです。(血液疾患患者さんでは不利益の方が大きいとの報告もあるので、慎重に考えるべきでしょう。) https://t.co/gOlJ7IZgC9 ht…
デキサメサゾンのCOVID-19に対する死亡リスク減少効果は、酸素吸入を要する中等症以上に限られるようです。(血液疾患患者さんでは不利益の方が大きいとの報告もあるので、慎重に考えるべきでしょう。) https://t.co/gOlJ7IZgC9 https://t.co/8FBoX9uwgT
@Earl_R_Robinson @julie4butte5 8/ Claim: “6 mg/d dexamethasone let cytokine storm run wild.” Evidence: The RECOVERY trial (6 mg up to 10 days) reduced mortality in patients needing O₂/ventilation and became the global standard. Higher doses haven’t shown clear superiority. Ref: https://t.co/fbUfrK2PS7
@Omnicentrist @DrNeilStone Actually We use scientific trials, which you're obviously ignorant of. Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/dCiuxXX8NL Own up, you're an arrogant ignorant moron with no self-awareness or an ounce of integrity.
@dickandtinasson @DrNeilStone Interesting @dickandtinasson = unaware for 5 years that Dexamethasone was trialed for COVID https://t.co/dCiuxXX8NL
@dickandtinasson @DrNeilStone The RECOVERY trial. https://t.co/mT8iAABp1F
@contantchris @Titithebest4 @LerouxArthur10 @Acermendax @Sonic_urticant @Alexandrt @lonnibesancon @wargonm @LacombeKarine1 @hervemaison @MicrobiomDigest @EricBillyFR @DgCostagliola @DrJeromeMarty @RReichstadt @MahmoudZureik @MyrtoTripathi Je vous laisse alors étudier les enseignements de Recovery et les bénéfices de l’usage de la dexamethasone https://t.co/kKJMTZyveG
@SammmmBB_ @CartlandDavid We encouraged skepticism of all interventions, including steroids. https://t.co/bXBhPAcLa9 RECOVERY eventually demonstrated a mortality benefit in admitted patients. https://t.co/xVOcjk7yYM https://t.co/9ee0i6QNZh
@Earl_R_Robinson @DocAhmadMalik Nonsense https://t.co/haqlipcDIQ.
@JCF4004 @DrNeilStone https://t.co/C5e8PLPvlU
@BTHBcRMY @DrNeilStone The RECOVERY trial: https://t.co/C5e8PLOXwm
@DrNeilStone When there is sufficient evidence to accept a claim. Dexamethasone met that burden of proof showing an objective mortality benefit. https://t.co/xVOcjk7yYM Ivermectin did not meet the burden of proof to warrant accepting that it was an effective treatment for C19
@stewak2 @DrNeilStone @TheChiefNerd Our ability to detect infection increased dramatically, driving the IFR down. Mortality on critical care did not massively change. Steroids were amazing. They perhaps had a 3% effect on hospital mortality. https://t.co/3jsgSlXWEJ https://t.co/wlbyJ81rzt
@AlBowers1 @DrNeilStone
@DrNeilStone To clarify, an excellent clinical study was published in a top medical journal by July 2020, which proved how effective dexamethasone was and instantly set it as top choice worldwide This lighting speed especially shows the opposite of a conspiracy https://t.co/wiymr0S2LL
@BarryESharp @DrNeilStone That’s BS. Dex was used in a randomly controlled clinical trial in mechanically ventilated patients, those on non-invasive ventilation and those not being ventilated. Why would you not bother checking this stuff before waffling like that? https://t.co/zWRUS5VKLH
@BarryESharp @DrNeilStone Rubbish.The original trial compared dex to those who did not get dex completely separate to ventilation as an intervention.... https://t.co/6YRi8NJcnP.
@Shelleybe3 @DrNeilStone The article was published in July 2020! How you think an article about it could possibly have been published earlier than that is beyond me. https://t.co/0eURZ7Ok36
@vvalkyri @RogerSeheult @KUFanInMO Under 94% resting on room air. https://t.co/uhxCZ6mdHA
@mothrfunkr It’s not based on an anecdote. It’s based on RCTs. It’s not off label (I wrote off the shelf, meaning not a new drug). https://t.co/uL7rcnUMNC
Its the final day of #RespMas! Behind today's #advent window is the RECOVERY trial! www.nejm.org/doi/10.1056/... "Dexamethasone in Hospitalized Patients with Covid-19" @nejm.org 2021;384:693-704 #RespEd #medsky #pulmsky #lungsky #COVID
pubmed.ncbi.nlm.nih.gov/32678530/
@JBshakennotstir @JamesAbbott2013 @MhehedZherting @jordanbpeterson ivermectin would make money if it worked. and it would be used if there was evidence it works. Try dexamethasone instead: https://t.co/GD8wfu3F2t /5
@MrfMrp @Franck20270 "Chez les patients hospits C19, La dexaméthasone a réduit la mortalité à 28 jours chez ceux recevant une ventilation mécanique invasive ou de l’oxygène lors de la randomisation, mais pas chez les patients ne recevant pas d’assistance respiratoire." DOI: 10.1056/NEJMoa2021436
@ascot_john @toobaffled We 1st handled COVID19 the way we deal with pneumonia. Turns out that wasn't ideal as there is a lot more inflammation on the lungs. It was only once we started to administer Dexamethasone (cheap steroid) that ventilation worked better. https://t.co/27urz0lvl5
@heikkor @myllarni On. Esimerkiksi #remdesiviiri:stä ja #deksametasoni:sta @TheLancet - SOLIDARITY: https://t.co/Tb7Res11az @LancetRespirMed - IPDMA: https://t.co/Vce03aOMtD @NEJM - RECOVERY: https://t.co/FlXVDFCjpW #EBM #COVID
@SunstrumPaul @nickmmark @jvipondmd https://t.co/AffQcK5NMz
@RobertKennedyJr Dexamethasone is cheap and off-patent like hydroxychloroquine, yet Dexamethasone is effective for COVID-19 patients requiring oxygen. https://t.co/ZUhyAZJeUW
@fluidloading RECOVERY showed that Dexamethasone significantly reduced mortality in hospitalized, hypoxic people with COVID, which is exactly where it’s used. https://t.co/B36yaA5xTD In the first 9 months of use dexamethasone was estimated to save over a million lives https://t.co/P7pBMllPeB https://t.co/Zc2OxKrjW4
@nickmmark But "not among those who were receiving no respiratory support at randomization (17.8% vs. 14.0%; rate ratio, 1.19; 95% CI, 0.92 to 1.55)," right? https://t.co/i6k87icMRy You disagree or have other data?
RT @RogerSeheult: @RobertKennedyJr Like dexamethasone which was literally the cornerstone of COVID inpatient treatment? https://t.co/gwbNp…
@RobertKennedyJr Like dexamethasone which was literally the cornerstone of COVID inpatient treatment? https://t.co/gwbNpxhFoY.
@PaulRic56123559 Hypoxia in Covid infection may or may not follow your rigid time schedule, Paul. Mortality benefit to those requiring supplemental oxygen shown in the RECOVERY trial: https://t.co/FnK9pfW8ox
@SolomonMg @JustinGrimmer Look at this experiment (Randomized controlled trial) https://t.co/a7o9PXxqIA. They mention the population, intervention, comparison and the primary outcome very clearly in the abstract.
If someone is sick enough to require oxygen for COVID, corticosteroid treatment, which suppresses the immune system, leads to improved health outcomes. In short, there is a sweet spot for acute inflammation: Not too much, not too little is best. https://t.co/nmlSmOzgl5 5/16
@drdargaray @drjohnm @hvanspall @thiele_holger @VPrasadMDMPH Hi Diego!!! Here are my “two cents”: 1. The landmark open-label platform randomized controlled trial: https://t.co/FsW2UNP2ri 2. An excellent example to highlight the relevance of blinded intervention in a trial: https://t.co/KKfdg5gWIu
@covid_quest @RogerSeheult @DrJackieStone @stereomatch2 @Thinkerks @ichudov @drbeen_medical @DrSyedHaider @drakchaurasia @DarrellMello @OutOfTheDarkAge @MdBreathe @molsjames @PierreKory @drpaulmarik1 @farid__jalali @drnathimdladla @drkohilathas @philamillan @Aguirre1Gustavo @amareshskumar @CartlandDavid @NaturallyFTW @Parsifaler @Rpshahmemorial1 @arkmedic @deepakdeepak @richardursomd @SeivwrightTrudy @btysonmd @GeorgeFareed2 @Johnincarlisle @StevePhillipsMD @Text2MD @raoult_didier The Oxford Recovery trial showed that 6mg/day dexamethasone reduced hospital mortality by 17%. This was enough for NIH to include dexamethasone along with remdesivir in the hospital protocol. As for methylprednisolone, they said "insufficient evidence". https://t.co/wkOv7N3SD9
@nickmmark Not specifically crit care but included critical care patients - the recovery study: https://t.co/U6165h2ssa
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @LoLoWarn: 6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
6/6 https://t.co/QwyKhPJ7wi https://t.co/Yv3IBnLUqN https://t.co/5IeTUmDvuS https://t.co/khKDNj04we
RT @RogerSeheult: We were told that the system was rigged and that no cheap generic drug would therefore ever be studied and much less FDA…
RT @RogerSeheult: We were told that the system was rigged and that no cheap generic drug would therefore ever be studied and much less FDA…
For Hospitalized patients use dexamethasone... but I use methylprednisolone on outpatient basis and has rarely came to a point of hospitalizing patients https://t.co/0x74E5OMcS
RT @RogerSeheult: We were told that the system was rigged and that no cheap generic drug would therefore ever be studied and much less FDA…
RT @RogerSeheult: We were told that the system was rigged and that no cheap generic drug would therefore ever be studied and much less FDA…
We were told that the system was rigged and that no cheap generic drug would therefore ever be studied and much less FDA authorized for COVID-19. Then dexamethasone came along and blew up that narrative. It's now the cornerstone of inpatient management. https://t.co/uB5ZZTkU7D
RT @ArtavusO: @MartinZ_uncut Concentration pulmonaire VS concentration plasmatique. Net bénéfice pour la première mais ils choisissent la…
RT @ArtavusO: @MartinZ_uncut Concentration pulmonaire VS concentration plasmatique. Net bénéfice pour la première mais ils choisissent la…
@MartinZ_uncut Concentration pulmonaire VS concentration plasmatique. Net bénéfice pour la première mais ils choisissent la seconde qui demande un dosage toxique qui va être utilisé sur des personnes grandement affaiblies.
@SabinehazanMD @amareshskumar @DrJackieStone @deepakdeepak @jayukids @stereomatch2 @jamesforpeace @Thinkerks @RinoRooter @ichudov @drbeen_medical @DrSyedHaider @drakchaurasia @DarrellMello @OutOfTheDarkAge @MdBreathe @molsjames @PierreKory @drpaulmarik1 @farid__jalali @drnathimdladla @drkohilathas @philamillan @Aguirre1Gustavo @CartlandDavid @NaturallyFTW @Parsifaler @Rpshahmemorial1 @arkmedic @richardursomd @SeivwrightTrudy @btysonmd @GeorgeFareed2 @Johnincarlisle @StevePhillipsMD @Text2MD @raoult_didier @BretWeinstein @michaelmina_lab For those of us in the ICU, steroids was the cornerstone of therapy. https://t.co/uB5ZZTkU7D
@LeoFurlanPhD @rleitepacheco @NaimeDr @bcaramelli “no oxygen received” This is the largest RCT https://t.co/N3BC9SALfC https://t.co/Rrmil7ORBv
@NickHudsonCT @ShaulaetLesath @YouWhat1715936 @curlsforgurls Yet dexamethasone was shown to work. There goes your reasoning. https://t.co/BKyK62O4sG
@taurusg333 @raoulduke49 @bjurrows @Danny459673 @sduncanhealth @Arkout3 @crabb_vicki @TonyBaduy @ShaneAKAProp @JRNave @WendyOrent @mcfunny @DaveBla81093404 @Pouldeau61 @krebiozen @runhack @MsTrixter @TheFrankmanMN @Hurriquake @MONTMAN9500 @StuWizzle @Golfergirl2018 @dann58638436 @Scary7Dr @khoombu @BB0941167867205 @TakethatCt @AngryMouse23 @BigGuy4U86 @Kathmarval @AnnLove4All @encyclopath @1_TMF_ @Fornowago @FUDyou2 @Catheri49917567 @RadioColor @tonymac5 @groin_hammer @CyclopsSeesAll @doritmi @ScienceMonkey0 @Just4TheCause @zendogbreath @FormerAntivax @BruceFo43322941 @DK25769559 @BigBopp75348974 @provaxtexan @MarioMoney23 Provide evidence for "99.7% recovery rate" then factor in long covid. Ivermectin, hydroxychloroquine, with or without zinc does not work. https://t.co/3jEVT4pUdQ https://t.co/LUOqpZEtRe Steroids appear to be effective: https://t.co/kFoHwma0og
@nuhope2022 @J91U17 @Pouldeau61 @BurgerLab12 @ryanbeed @dirk_fasshauer @ptcjoneses @FiendInno @BB0941167867205 @ogilville1 @cbeckj @jilel76 @zee_parody @lazlowoodbine42 @MaureenStroud @MayassiSabia @mcfunny @PlatoonOps @JimeeLiberty @nickowe49445250 @TonyBaduy @Veeteejay1 @SoiferErica @nopoisonjabs @Monstercoyliar @doom37455413 @EmmaGabrie61897 @ScooterScience @Redbonegirl175 @dann58638436 @Shina20269455 @barryjohnreid21 @WendyOrent @LummHandy @Scary7Dr @IdunsDaughter @Greg_Alexson @Charlie81207771 @JKelleyK @iamromieb @SynthIge @Nicoleg425 @MsTrixter @FreedomTruth13 @pawley_robert @tomsirolimus @villagerssn @kevinault @UDunningKruger @VaughnMises The study I believe you were referring to was in the UK recovery trial. Details matter. https://t.co/9sP0mTy4Jg
@SearleDj @thisisnothappen @TakethatCt @ItsScienceJim @BreezerGalway @pj_montgomery @glenpyle @SACricketmag https://t.co/8IPDaRWUlb.
@NickHudsonCT Dexamethasone says hi. https://t.co/HoURlyFPrZ
@C_Kavanagh @hugowiz He's engaged in Matt-Taibbi-levels of making stuff up that involves , for example, pretending the repurposed drug dexamethasone does not exist. Nor budesonide. Nor... https://t.co/325pYWlXnt https://t.co/3jgiAqoLVS https://t.co/iXZdkWxI65
RT @anish_koka: The RECOVERY trial found 6mg of dexamethasone daily reduced mortality in hospitalized patients with COVID requiring oxygen.…
RT @anish_koka: The RECOVERY trial found 6mg of dexamethasone daily reduced mortality in hospitalized patients with COVID requiring oxygen.…
RT @anish_koka: The RECOVERY trial found 6mg of dexamethasone daily reduced mortality in hospitalized patients with COVID requiring oxygen.…
RT @anish_koka: The RECOVERY trial found 6mg of dexamethasone daily reduced mortality in hospitalized patients with COVID requiring oxygen.…
The RECOVERY trial found 6mg of dexamethasone daily reduced mortality in hospitalized patients with COVID requiring oxygen. Any rationale for giving 1 gram of solumedrol in lieu of that ? Cc @AnilMakam @phlegmfighter https://t.co/hTvQ1jWtx1
@geostylegeo On the other hand high dose steroids are effective in critically ill patients. https://t.co/avOwqoQKLb
@RyanMarino Not that logical thought really matters when it comes to those who've dived down the antivax rabbit hole, but my goto on this is always dexamethasone. If ivermectin was "suppressed" by Big Pharma for maniacal purposes, why wasn't it "suppressed" too? https://t.co/ROOOcMYXbA
RT @PharmacyToDose: #TrialOfTheDay for July 28th is the RECOVERY trial, published ahead of print on this date in @NEJM A testament to the…
#TrialOfTheDay for July 28th is the RECOVERY trial, published ahead of print on this date in @NEJM A testament to the medical community coming together for COVID-19 research in the early stages of the pandemic Open-access Article link: https://t.co/vIi44rWinM #pharmicu https://t.co/1Ce7si4T8W
@smartwookiee @Monstercoyliar @LBHumphries @Shina20269455 @ryanbeed @Pouldeau61 @richykirsh @TonyBaduy @cbeckj @nickowe49445250 @MsTrixter @Veeteejay1 @BurgerLab12 @Scary7Dr @reacharoundu @WendyOrent @MaureenStroud @zee_parody @FreedomTruth13 @JimeeLiberty @pawley_robert @doom37455413 @ptcjoneses @f_kyburz @MayassiSabia @SynthIge @tomsirolimus @nopoisonjabs @JKelleyK @IdunsDaughter @villagerssn @kevinault @UDunningKruger @VaughnMises @mcfunny @GiveABJGoToJail @nuhope2022 @addict_opiate @Nicoleg425 @ogilville1 @TackettWendi @PlatoonOps @Kathmarval @provaxtexan @SkepticalMutant @ConsequentialBr @Nockit1 @LouforFreedomL1 @ZeetubesII Have you not heard of Google? https://t.co/Es42sYmlqv
This probably most relates to the hyperglycaemia induced by dexamethasone, which saves lives, changing the glucose/COVID19 relationship. 4/... https://t.co/JJ0Vbhq3bf
@JeanLucPicard3 @KateShemirani RECOVERY showed us that giving steroids in milder cases (ie patients not receiving oxygen or mechanical ventilatory support at baseline) increased mortality. The study is here if you wanted to reread it. https://t.co/yHLLLcMVi8
@4Clearsky @Sethmr1989 @KarensComebacks @jonathanstea "Doctors have always been allowed to repurpose existing drugs." For sure - and Dexamethasone, an existing drug, is effective in persons with COVID-19 pneumonia https://t.co/ybd4wdHxBR
@HamHead5813 @FoxPharmD @gorskon @RobertKennedyJr You said it was suppressed. That's a lie, since it was actually studied, and the results published + widely shared. That shows you lied, which is why you evade my question that exposes your lie. https://t.co/r7ecCd1Xbn https://t.co/BKyK62O4sG
@HamHead5813 @FoxPharmD @gorskon @RobertKennedyJr You're again asking leading questions based on lies you made up. For example, dexamethasone is cheap. You'll never have integrity. https://t.co/325pYWlXnt https://t.co/3jgiAqoLVS
@carolina_bonita Dexamethasone is cheap and off-patent like Ivermectin, but Dexamethasone is effective against SARS-CoV-2 based on double-blind randomized clinical trials with inert placebo. Why is dexamethasone not suppressed for severe SARS-CoV-2 cases requiring oxygen? https://t.co/czFsEIU1Dt
RT @FredBeamer3: @Jikkyleaks @PhilipRafferty5 @FillmoreWhite @PwningOrpheus @Debunk_the_Funk SARS-CoV-2 was created by bats and transmitted…
RT @FredBeamer3: @Jikkyleaks @PhilipRafferty5 @FillmoreWhite @PwningOrpheus @Debunk_the_Funk SARS-CoV-2 was created by bats and transmitted…
@Jikkyleaks @PhilipRafferty5 @FillmoreWhite @PwningOrpheus @Debunk_the_Funk SARS-CoV-2 was created by bats and transmitted via intermediate host to humans in multiple zoonotic events. Dexamethasone is not being withheld to treat severe SARS-CoV-2 cases requiring oxygen. https://t.co/qkRiGrmUIa
RT @FredBeamer3: @PhilipRafferty5 @FillmoreWhite @PwningOrpheus @Debunk_the_Funk Why isn't dexamethasone, corticosteroids, being suppressed…
@PhilipRafferty5 @FillmoreWhite @PwningOrpheus @Debunk_the_Funk Why isn't dexamethasone, corticosteroids, being suppressed for COVID-19 treatment? Dr. Fauci didn't work with Judy, who worked at NCI and not NIAID. https://t.co/qkRiGrmUIa
RT @FredBeamer3: @Javlaskitstovel @Quelle_33 @stkirsch Why isn't dexamethasone being suppressed for COVID-19 patients? Dexamethasone, which…
この逆転は、2年以上前に指摘されていたことではある。 Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/1QfkkOBB2w https://t.co/qIJEx1wOBA
RT @medical_xpress: Researchers identify how steroids benefit #severeCOVID-19 patients @UofCincy @nejm @frontiersin https://t.co/EbQRnxSBwz…
RT @medical_xpress: Researchers identify how steroids benefit #severeCOVID-19 patients @UofCincy @nejm @frontiersin https://t.co/EbQRnxSBwz…
RT @medical_xpress: Researchers identify how steroids benefit #severeCOVID-19 patients @UofCincy @nejm @frontiersin https://t.co/EbQRnxSBwz…
Researchers identify how steroids benefit #severeCOVID-19 patients @UofCincy @nejm @frontiersin https://t.co/EbQRnxSBwz https://t.co/7eQZy9O8vH
Esse medicamento foi um dos maiores triunfos científicos da medicina. Durante a pandemia do COVID foi uma medicação fundamental na redução da morbi-mortalidade dos casos graves.
RT @AtomsksSanakan: @VigilantFox @RobertKennedyJr Silly disinformation, since dexamethasone was shown to be effective + added to standard o…
@VigilantFox @RobertKennedyJr Silly disinformation, since dexamethasone was shown to be effective + added to standard of care for COVID-19 before vaccines received EUA. Neither you nor RFK Jr. are honest, as expected of the 'vaccines cause autism' crowd. https://t.co/325pYWlXnt https://t.co/3jgiAqoLVS
@DrHeidiFlori @Martin_Kneyber @PALISInet @PROSpect_Study I totally agree. How far we are from that technology? DexARDS showed 15% absolute mortality reduction even without having biomarker enrichment
@JHorrn @_everythingism @mtaibbi @RichardDaleFitz Taibbi also acts like it was about opposition to Trump, which is just nonsense that shows Taibbi has no clue what "dexamethasone" is. https://t.co/325pYWlXnt https://t.co/3jgiAqoLVS https://t.co/mt66G12Hxg https://t.co/iXZdkWxI65 https://t.co/n9SP2EfU0J https://t.co/Uan71XIYmZ
@annamerlan @dfreedman7 Re: "it's really disappointing that so far no older drugs can be re-purposed to fight COVID" Dexamethasone was repurposed + shown to work. But yes, Taibbi's ivermectin/COVID-19 reporting was tripe. https://t.co/3JXNZUDjpD https://t.co/BKyK62O4sG https://t.co/xsnB3gZXkp
@Richbink @ThomasHarrigan8 @JackSlaterPT #awkward https://t.co/FEQw7OW4yu.
10/T Repurposed drugs were studied before, during, and after Trump's mention of HCQ. One of the biggest pre-vaccination success stories was dexamethasone, a repurposed steroid. https://t.co/uphLKujulq https://t.co/BKyK62O4sG https://t.co/mt66G12Hxg https://t.co/n9SP2EfU0J https://t.co/RaQ79BvGUp
Dexamethasone in Hospitalized Patients with Covid-19 DOI: 10.1056/NEJMoa2021436 Dexametasona 6 mg por 10 días en pacientes con soporte respiratorio disminuyó la mortalidad a 28 días, la necesidad de VMI o su destete, necesidad de TRR y aumentó el alta hospitalaria. https://t.co/fCSLaFAJiP
@MarioNawfal dexamethasone in covid id cheap— but it was a large NEJM study https://t.co/mnKJqDUaV8
RT @MartinLandray: Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- vent…
RT @MartinLandray: Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- vent…
RT @MartinLandray: Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- vent…
RT @MartinLandray: Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- vent…
RT @MartinLandray: Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- vent…
RT @MartinLandray: Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- vent…
Low-dose steroids (dexamethasone 6 mg daily) reduces mortality in patients with hypoxia (those receiving oxygen +/- ventilatory support) https://t.co/SMnGKFZkHj https://t.co/StU9ITN9mw
This month our article is: https://t.co/Fwh2L357rz #journalclub
@Palanganamos @AsturResiste @Buenrolloreturn https://t.co/8i3H0PTTvM
Moreover, many of them cite the RECOVERY trial as supporting evidence for this warning. (
@PierreKory This simply isn’t true. Here is a good example - dexamethasone in covid19 https://t.co/4QscpJqYss
Long #COVID: With no treatment options, it's little wonder people are seeking unproven therapies like '#blood washing' @ConversationEDU @bmj_latest https://t.co/IU5EhGlOXV https://t.co/UzL0gwbJTb
”Repurposing” af eksisterende lægemidler til andre indikationer er ikke nyt og dexamethasone er et godt eksempel indenfor COVID-19 behandling https://t.co/FMIXMn2BOt 9/19 https://t.co/pAgKKtjOM6
Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/CSsr9ojefH
@Brinett14624310 @Sebasti71137093 @terryfox007 @Marc_Doyer @verity_france @BFMTV Pas aussi simple les corticoïdes, ça marche pour réduire la mortalité dans certains situations que les médecins connaissent. https://t.co/JtjG1Uf9SM
RT @MarReanimacio: El @NEJM publica los resultados preliminares del grupo #RECOVERY: "Dexamethasone in Hospitalized Patients with Covid-19"…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
RT @Katsumata_Nori: 新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/…
新型コロナに使用するデカドロンは、4mgで薬価が29.9円新型コロナには、6mg使うので、45円/日ととてつもなく安いんです。この薬剤が承認されたのは、大規模なランダム化比較試験で有効性が証明されたからなんです。https://t.co/fij0L0EbW6
@DonEford @stargazing90 Steroid hormones lessen inflammation and cytokine storm... see the synthetic hormone medicine dexamethasone. Used in COVID-19, also studied. https://t.co/1qsX7zGak9
Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/uWP6rEuKPi
@Lewi210 @DrSimonAshworth They haven't been ignored at all, they've been tested in huge trials. Unfortunately they don't actually work to treat COVID, so that's why they aren't used. Other medicines, including cheap longstanding ones like dexamethasone, do work, so have been used: https://t.co/ROOOcMYXbA
@sdavis1945 @ExptKnitter @docjoe77 @RMConservative Antibiotics for a virus? Hmm. I don't know which steroids you both took but the research supports use in severely ill patients https://t.co/pu1r30yRtm Doctors aren't prescribing them for all and sundry because the data don't support it, and they have side effects themselves
@Islands808RAH Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. https://t.co/OBWCItQv1Q
@iamcryptonanda @100trillionUSD His claims that hydroxychloroquine treatment works are false. Several large studies show hydroxy treatment has no effect, e.g.: https://t.co/6l89WAgzrd Other drugs that work were found and are being used: https://t.co/FVi7gHwlQx Our medical professionals are doing their best.
RT @raoult_didier: Discovery n'a rien apporté à la connaissance, mais les anglais ont fait pire : ils ont évalué dans un essai la corticoth…
@misik . Nochmal, Ivermectin rettet Leben! . Anderes Medikament, Dexamethason, ist auch für Tiere, übrigens. (Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/o0bF90j0gs) . https://t.co/oGjO2v5Vv5
@Stonnie19 @Santaflow_fenix @BobbyFi57075392 Y aquí sobre la Hidroxicloroquina. https://t.co/tkCieqmKFM
"La humilde dexametasona y su efecto salvavidas" 2/n En hospitalizados con COVID-19, dexametasona demostró disminuir la mortalidad a los 28d de los que estaban recibiendo ventilación mecánica invasiva u oxígeno solo. Fuente: https://t.co/pA5v7VQOJQ https://t.co/J5N2Eqg3Y4
RT @OxfordMedSci: ICYMI: The #RECOVERYTrial team win BMJ's 2021 UK Research Paper of the Year Award for 'Dexamethasone in Hospitalized Pati…
This year's @bmj_latest award research paper of the year changed practice worldwide in the treatment of covid-19. Dexamethasone in Hospitalized Patients with Covid-19 Find out more: https://t.co/InVg2j322k Read the award-winning article here: https://t.co/Lvc8bnTJV7
Оба этих препарата имеют более низкие концентрации у плода либо с ограниченным прохождением через плаценту, либо с быстрым плацентарным метаболизмом. https://t.co/EQHkRPXc24
RT @OxfordMedSci: ICYMI: The #RECOVERYTrial team win BMJ's 2021 UK Research Paper of the Year Award for 'Dexamethasone in Hospitalized Pati…
RT @OxfordMedSci: ICYMI: The #RECOVERYTrial team win BMJ's 2021 UK Research Paper of the Year Award for 'Dexamethasone in Hospitalized Pati…
RT @OxfordMedSci: ICYMI: The #RECOVERYTrial team win BMJ's 2021 UK Research Paper of the Year Award for 'Dexamethasone in Hospitalized Pati…
ICYMI: The #RECOVERYTrial team win BMJ's 2021 UK Research Paper of the Year Award for 'Dexamethasone in Hospitalized Patients with Covid-19'. The paper describes the discovery of the world’s first effective, readily available treatment for #COVID19. https://t.co/OGo8T83tW8
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/s9dkAR52Fm
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @ABsteward: Fantastic, well deserved recognition for #Recoverytrial RECOVERY Trial paper “Dexamethasone in Hospitalized Patients with Co…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @MartinLandray: Congratulations & many thanks to our wonderful colleagues @Oxford_NDPH & @NDMOxford, collaborators at #NHS hospitals acr…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @bmj_latest: Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, a…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
RT @Oxford_NDPH: Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in…
Congratulations to the #RECOVERYTrial team on winning UK Research Paper of the Year at #theBMJawards for 'Dexamethasone in Hospitalized Patients with COVID-19'! Find out more
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report ; RECOVERY trial : @DrOhoudAljuhani @icu_pharm #icuRxlesson https://t.co/3jYS5A4YrZ
@TheJohnBream https://t.co/qJD35yeOwG
Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/eGBh7cF9te
@mrthijsdejong @justkiddin1980 @Su5anne @DieTukkerfries Dexamethasone (in Hospitalized Patients with Covid-19 | NEJM ) voorkomt dood door Covid19 in 23-26% van de gevallen. Vaccins voorkomen de dood door Covid19 in 99,995 van de gevallen. https://t.co/navHoJasRT
RT @RayMasuda: @8WfKVClA7tRNaMm 私も軽症患者さんにデキサメタゾンを投与するべきではないと思います。 ただ、元の論文(Dexamethasone in Hospitalized Patients with Covid-19)では、「酸素療法を必要と…
@8WfKVClA7tRNaMm 私も軽症患者さんにデキサメタゾンを投与するべきではないと思います。 ただ、元の論文(Dexamethasone in Hospitalized Patients with Covid-19)では、「酸素療法を必要としない患者さん」の死亡率はデキサメタゾン17.8% 対偽薬14.0%でデキサメサゾン群が高い傾向はありますが有意差は無いです。(続)
RT @carpe_diem0820: 最終報告 デキサメタゾン使用で28日以内の死亡リスク低下(aRR0.83; 95%CI 0.75-0.93) 挿管患者でaRR 0.64(0.51-0.81)ではその傾向が顕著だが 酸素不要な患者では1.19(0.92-1.55)と有意差…
Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/AViO8lPKtg
RT @carpe_diem0820: 最終報告 デキサメタゾン使用で28日以内の死亡リスク低下(aRR0.83; 95%CI 0.75-0.93) 挿管患者でaRR 0.64(0.51-0.81)ではその傾向が顕著だが 酸素不要な患者では1.19(0.92-1.55)と有意差…
Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/dvEfHXDoSF
”Dexamethasone in Hospitalized Patients with Covid-19" とりあえずこれは基本かと https://t.co/kCqah7Owtx
RT @doctorneyro: In #patients #hospitalized with #COVID19, the use f #dexamethasone resultd in lower #28daymortality amng those who were re…
Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/NyU3WIPUXo
Referencias: RECOVERY Collaborative Group, Horby P, Shen WL, Emberson JR, y cols. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 25 Feb 2021;384(8):693-704. doi: 10.1056/NEJMoa2021436. PMID: 32678530. https://t.co/4An60Gwfwu
CFR & IFR, https://t.co/FsChPH7Mgu fatality rate https://t.co/WhW0bhK17h
@TCarraghan @PierreKory You're just posting memes and screenshots from a heavily biased web site. I'll just give you more data until you come with some of your own. https://t.co/SNEHYPBUdG
What we have learnt about COVID-19 treatment in 2021. Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/47EEqxVj8z
Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/BJpruq7xkC
RT @Dietis_Lab_UCY: Ή όπως η δεξαμεθαζόνη, όπου τα δεδομένα της μελέτης RECOVERY βγήκαν τέλη Φεβ '20 και ο ΕΜΑ το πρόσθεσε στο πρωτόκολλο θ…
Ή όπως η δεξαμεθαζόνη, όπου τα δεδομένα της μελέτης RECOVERY βγήκαν τέλη Φεβ '20 και ο ΕΜΑ το πρόσθεσε στο πρωτόκολλο θεραπείας τον Σεπ '20. Στη βαθμολογία της μεθόδου μας (max 1 - min 0.68), η ρεμντεσιβίρη είχε σκορ 1. 20/ https://t.co/OUzCek4ppW
@StephanCaraibes #COVID19 #Dexamethasone #NEJ Chez les patients hospitalisés avec Covid-19, la #dexaméthasone a entraîné une mortalité à 28 jours plus faible chez ceux qui recevaient soit une ventilation mécanique invasive soit de l'oxygène seul. https://t.co/oveCPqzsvI
@coeurdestemps @medicalfollower @AssoCovid @autrement_votre #COVID19 #Dexamethasone #NEJ Chez les patients hospitalisés avec Covid-19, la #dexaméthasone a entraîné une mortalité à 28 jours plus faible chez ceux qui recevaient soit une ventilation mécanique invasive soit de l'oxygène seul. https://t.co/oveCPqzsvI
#COVID19 #Dexamethasone #NEJ Chez les patients hospitalisés avec Covid-19, la #dexaméthasone a entraîné une mortalité à 28 jours plus faible chez ceux qui recevaient soit une ventilation mécanique invasive soit de l'oxygène seul. https://t.co/oveCPqzsvI
RT @shreya__kataria:
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @spkalantri: In the RECOVERY trial (Dexamethasone in Hospitalized Patients with Covid-19), of the 2104 patients assigned to receive dexa…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @spkalantri: In the RECOVERY trial (Dexamethasone in Hospitalized Patients with Covid-19), of the 2104 patients assigned to receive dexa…
RT @spkalantri: In the RECOVERY trial (Dexamethasone in Hospitalized Patients with Covid-19), of the 2104 patients assigned to receive dexa…
RT @spkalantri: In the RECOVERY trial (Dexamethasone in Hospitalized Patients with Covid-19), of the 2104 patients assigned to receive dexa…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
In the RECOVERY trial (Dexamethasone in Hospitalized Patients with Covid-19), of the 2104 patients assigned to receive dexamethasone, 24% were diabetic. No trial patient developed #Mucormycosis. 2/6
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
RT @DocVatsa: Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red lin…
Dexamethasone in Covid (reminder) Only helps when patient is ON OXYGEN THERAPY, not otherwise. Pic 1. The lower the red line, the better. Note when not on oxygen, dexa has 'slight' opposite effect (not significant) Steroid misuse can help the virus! https://t.co/5g3daoRFvE https://t.co/ab2E5JuguX
RT @shreya__kataria:
RT @shreya__kataria:
https://t.co/EeBbWwEavB
Open Access UCL Research: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report https://t.co/nICJImzGXm
JOURNAL CLUB: 3pm today. Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/VDssMOGH5Q
RT @primosome: Dexamethasone in Hospitalized Patients with Covid-19. It's cheap, effective, clinically proven remedy against Covid-19. To b…
Dexamethasone in Hospitalized Patients with Covid-19. It's cheap, effective, clinically proven remedy against Covid-19. To be only administered in hospital settings under doctor's supervision. https://t.co/EZS7ophZ1z
@Fizz_DI Final reportのサブグループでは、no oxygen患者への投与は有意差はないものの、悪化する傾向ってデータですよね(^_^;) https://t.co/eKu1uzQJL1
NHS Ayrshire and Arran staff have been credited in the New England Journal of Medicine for being a part of the international RECOVERY Study to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19. https://t.co/frZHlUl8wD
https://t.co/lq5WW13mw4
https://t.co/gFvPGy7An4. https://t.co/DQZY4KZvKx. https://t.co/96ViDwu6a1. https://t.co/isIsYn9Oji https://t.co/hvlXreKqvR https://t.co/uPdTDeBH46. https://t.co/0YAnw9Wi5t
The use of dexamethasone resulted in lower 28-d mortality among those who were receiving either inv. mech. ventilation or O2 alone at randomizat. but not among those receiving no respiratory support. Dexameth. in Hospitalized Patients with Covid-19 | NEJM https://t.co/RsJxlQWSnf
Why Are COVID Fatality Rates Dropping? https://t.co/OXOYEqmQxm via @YouTube
Just Liked on YouTube: Why Are COVID Fatality Rates Dropping? https://t.co/416kQJfoGr
RT @RoyalPapLib: #papworthauthors new publication: Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. https://t.co/…
RT @RoyalPapLib: #papworthauthors new publication: Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. https://t.co/…
#papworthauthors new publication: Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. https://t.co/8i0phstV90. #Dexamethasone #COVID19 #recoverytrial @rintoul_robert @KittyPaques @stephen_t_webb https://t.co/Xeis3zf1kD
@Lord_Berto @edigram @VirtualRaven @SimonaBosch @tenfris1 @UgoQuinzi @Il_Corvo_nero @Trail7439 @azangrillo @AStramezzi Intanto ti regalo questo studio inglese sul dexametasone (corticosteroide). Anche questo parte della #TERAPIADOMICILIARECOVID19. https://t.co/VAaf6Gt57S
Dexamethasone in Hospitalized Patients with Covid-19. https://t.co/zD4QXTICWM https://t.co/FAXhlgDKjd #LocalAuthorThursday https://t.co/UP99NyOZVD
RT @SheilaSBearden1: https://t.co/sri8WGsaSJ https://t.co/9NDD6vENCE
Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://t.co/u0OqMPHZ9q
https://t.co/sri8WGsaSJ https://t.co/9NDD6vENCE
2021/2/25出版分 twitterでバズった論文 全分野 Dexamethasone in Hospitalized Patients with Covid-19 https://t.co/xbOFrRgfPh Tweets: 8505 人工呼吸器がつくCOVID-19患者においてはステロイドが有効。もはやCOVID-19に対してはステロイド一強なのでは?
RT @JeanMichelFleur: @doctormosqueda The RECOVERY Collaborative Group. 2021. Dexamethasone in Hospitalized Patients with Covid-19. New En…
The RECOVERY Collaborative Group. 2021. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384(8), pp.693–704. Available at: https://t.co/BaiDm3Z4C8 https://t.co/sHpDKiJAmF
@doctormosqueda The RECOVERY Collaborative Group. 2021. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384(8), pp.693–704. Available at: https://t.co/BaiDm3Z4C8. https://t.co/J5Tq9xcpIY
RT @Saber_IMSS: En este ensayo controlado que compara tratamientos en pacientes hospitalizados con #COVID19 se indicó que al azar, algunos…
En este ensayo controlado que compara tratamientos en pacientes hospitalizados con #COVID19 se indicó que al azar, algunos de ellos recibieran dexametasona oral o intravenosa por hasta 10 días o que recibieran atención habitual. Encuentra el artículo aquí: https://t.co/36o9wbLJ1w https://t.co/CdX5mjJSw4
The RECOVERY Collaborative Group. 2021. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384(8), pp.693–704. Available at: https://t.co/BaiDm3Z4C8. https://t.co/Q7gbIhXGtY https://t.co/tv4551dz0D
El análisis de subgrupos es del RECOVERY: dexametasona en hospitalizados por COVID-19 según su soporte respiratorio basal. https://t.co/KSUoZwMA3L
RT @EmilioAlegre1: @rabadan_andres Aquí lo tienes, un abrazo. https://t.co/KSUoZwMA3L
@Covid19Crusher @AvonandsomerRob I don't understand what that graph is showing. Going to the linked site and searching on "dexamethasone" leads to one paper from July 2020 which concludes that the drug does reduce mortality (from 41% to 29%): https://t.co/Bfr9x66rjD
RT @kaparta: Here's the latest #SciShow episode I wrote. Enjoy and share! "Why Are COVID Fatality Rates Dropping?" https://t.co/wNPNnXwwVk…
Why Are #COVID Fatality Rates Dropping? https://t.co/FSwdVMDZ6l
RT @EkolojiE: "Bu fayda düzeyi, COVID-19 için "kanıtlanmış tek tedavi" olarak manşetlere çıkan anti-enflamatuar steroid ilaç olan deksameta…
Why Are COVID Fatality Rates Dropping? https://t.co/s5vpyOkFyh via @YouTube
RT @SciShow: Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors…
.@SciShow publishes daily videos about current questions from the world of science. https://t.co/UcrJvyH7ES Newsletter: https://t.co/jsq9u5dDiI #biology #science #scishow #trivia #COVID19 #fatalityrates #dropping https://t.co/fuqzV2NMNy
Why Are COVID Fatality Rates Dropping? https://t.co/VaRKopcDgE via @YouTube
Why Are COVID Fatality Rates Dropping? https://t.co/RpeXk9ea0G via @SciShow
Why Are COVID Fatality Rates Dropping? #COVID19 https://t.co/SgT85hDf35
Her "lol not scientifically proven idc" Science today: https://t.co/QEWXp2Vf0P (leaning further into the hypothesis)
Here's the latest #SciShow episode I wrote. Enjoy and share! "Why Are COVID Fatality Rates Dropping?" https://t.co/wNPNnXwwVk #COVID19 #COVID #Fatalityrate #Fatalityrates #coviddeath #covidhope #vaccination
Why Are COVID Fatality Rates Dropping? @ https://t.co/ivE2rwZYHL https://t.co/0YPBRQx7xX
RT @SciShow: Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors…
RT @SciShow: Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors…
RT @SciShow: Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors…
RT @SciShow: Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors…
Why Are COVID Fatality Rates Dropping? https://t.co/Ak48xmTk9j via @YouTube
RT @SciShow: Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors…
https://t.co/so3rF4P6C0
Near the end of 2020, we got some puzzling but good news: COVID-19 fatality rates have been dropping. Here are a few factors that might help explain why we’re seeing this trend. https://t.co/2zpxTIiCOy https://t.co/o25gP55j28
https://t.co/yDqDZ62IuV My understanding of videos/information related to COVID-19 has changed dramatically since starting placement in a hospital...
New video by SciShow: Why Are COVID Fatality Rates Dropping? https://t.co/r8JZA0wQGm
@michaelmcgeebjj @DrZeroCraic https://t.co/I3IUVDffra
@MeganXDiaz @OrlandoRPN @AdrianaSegovian @dredgarbarragan Y en este caso, el estudio inicialmente británico RECOVERY ha demostrado que la Dexametasona sirve. https://t.co/ANcLDYmRsG ¿que hay Cushing? Probablemente ¿Que hay supresión adrenal? ¿Que puede haber sobreinfección? Tal vez. Pero te disminuye mortalidad. Así de "no tan simple"
@AdrianaSegovian @dredgarbarragan Lo bueno es que no es lo que tú crees, sino lo que la evidencia muestra. La dexa tiene indicaciones precisas en COVID y salva vidas. Lee los resultados del Recovery: https://t.co/GCPZlKHWDL
@gemmspp @Jajaja69709622 @EnricBernedaBen @nccarmon @ej_molina_c @jbarrios107 @carmenvivomivid @anarkristo @MariaJe45669909 @MoChao33 @no_tontos @AndresJ777 @Hondoncity @SalvaGarca4 @yeyete2000 @ldu2004 @atlefreak1 @VScienco @Javier_SB23 @EsteveMaspons @Tabbygraycat @Conactico @iPodMusica @PunkiSantxez @Jean9167632913 @JoanZeitgeist @Nestor2311Reyes @BK1_wazing @LeilaAscariz @crisis_historia @MatiMatarredona @donvanchipotin @NightHowl11 @guillen_blanchy @ACharlatans @FerFrias @Candelaenlaluna @A_Corrales_1020 @JonatanRV79 @vicgagliardi @aprobandomates @ojokurioso @Pau_Vega13 @Incognoscible_ @b0rmeg4 @_senor_pollo @creativemusic11 @JALGUERRERO @msalaet62 Por ejemplo, la dexametasona https://t.co/Gl0QE4rub1
RT @Luis_Corral_Gud: Sin embargo, ya vimos con RECOVERY-DEXAmetasona que no era así. Quién más se beneficaba, en términos de mortalidad, er…
RT @Luis_Corral_Gud: Sin embargo, ya vimos con RECOVERY-DEXAmetasona que no era así. Quién más se beneficaba, en términos de mortalidad, er…
RT @Luis_Corral_Gud: Sin embargo, ya vimos con RECOVERY-DEXAmetasona que no era así. Quién más se beneficaba, en términos de mortalidad, er…
Sin embargo, ya vimos con RECOVERY-DEXAmetasona que no era así. Quién más se beneficaba, en términos de mortalidad, era quién estaba intubado. https://t.co/V5OtEDzCT8 https://t.co/qJX8RCifAD
RT @sgdambrauskas: 20/ Pandemia. Se necesitaba evidencia. #RECOVERYTrial
20/ Pandemia. Se necesitaba evidencia. #RECOVERYTrial
@a_serpaneto @AidanBurrell @TonyTrapani1
@PatrickLowe9 He's only getting steroids if he is requiring oxygen though! https://t.co/rYovIRSbKL
RT @AleCrespoF: Lo que ha demostrado que funciona Dexametasona: evaluado en +6.000 pacientes. Redujo significativamente la mortalidad en p…
@ScientistMel @THERealN8SNAKE @PrinceOfAtheism @Drstevenhobbs This one is https://t.co/giO6YIg2bd
RT @iceman_ex: @WICSBottomLine The story of steroids in #COVID19 is fascinating From caution re: viral shedding https://t.co/jvcaLkvcBZ T…
@WICSBottomLine The story of steroids in #COVID19 is fascinating From caution re: viral shedding https://t.co/jvcaLkvcBZ To RECOVERY-Dexamethasone as we know it today https://t.co/WvrmZvgEno
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM https://t.co/oQW3cDe15L
RT @raoult_didier: Discovery n'a rien apporté à la connaissance, mais les anglais ont fait pire : ils ont évalué dans un essai la corticoth…
@giridar100 @HaryaxPathak @pash22 @ProfSomashekhar @Dharmen46587056 @AnantBhan @GorwayGlobal @anupsoans Giri I thought recovery trial is about moderate to severe disease. In fact they went ahead to say use of steroid in mild is dangerous. I hope I didn’t misunderstand what you said. Using steroid in mild disease is dangerous. https://t.co/644PeoDnlX
@bsandman66 @MicahPollak RECOVERY trial paper: https://t.co/IpJXIawcnl
RT @raoult_didier: Discovery n'a rien apporté à la connaissance, mais les anglais ont fait pire : ils ont évalué dans un essai la corticoth…
RT @raoult_didier: Discovery n'a rien apporté à la connaissance, mais les anglais ont fait pire : ils ont évalué dans un essai la corticoth…
RT @PatriciaLanP: El fármaco dexametasona, que reduce la respuesta inflamatoria y se usa para tratar muchas enfermedades inflamatorias, ha…
5/ In fact, those found to theoretically benefit from HPF are the same patients shown to benefit from dexamethasone RECOVERY: https://t.co/1HwxRMiR0e Dexa: ⬇️less invasive ⬇️less expensive ✅more widely available
Referencia bibliográfica: Horby P, Lim W, Emberson J, Mafham M, et al. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. The New England Journal of Medicine. [https://t.co/0jqCKEAyym]
Vamos falar sobre um remédio que tem realmente efetividade no combate ao Covid? Estudos indicam q Corticoide dexametasona vem sendo efetivo EM PACIENTES JÁ HOSPITALIZADOS. https://t.co/dxCFUxwUSk Há risco enorme de se tomar preventivamente: https://t.co/LFkDTmCnGI
#recoverytrial renal outcomes analysis ongoing seems like - covid19 use of dexamethasone https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home
****Preprint of #RECOVERY trial***** via @medrxivpreprint Effect of #Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1 #COVID19 #SARSCoV2
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1